Natori Y, Natori Y, Nishimura T, Yamabe H, Iyonaga K, Takeya M, Kawakami M
Research Institute, International Medical Center of Japan, Tokyo, Japan.
Exp Nephrol. 1997 Jul-Aug;5(4):318-22.
Glomerular epithelial cells (GECs) have been shown to be one class of target cells in immunological and nonimmunological glomerular injury of glomerulonephritis, some cases of which are accompanied by infiltration of glomeruli by monocytes/macrophages. In this study we tested whether GECs in culture produce monocyte chemoattractant protein-1 (MCP-1), a potential molecule responsible for monocyte recruitment in inflammation, and whether the production is inhibited by glucocorticoid. GECs were obtained from outgrowth of rat glomeruli. Levels of MCP-1 mRNA and protein were determined by Northern blot analysis and ELISA, respectively. Northern blot analysis revealed the expression of MCP-1 mRNA in cytokine-treated GECs. The expression of MCP-1 mRNA was inhibited by dexamethasone. Quantitative analysis by ELISA confirmed the production of MCP-1 protein by GECs and the inhibitory effect of dexamethasone. These results indicate that cytokine-treated GECs produce and secrete MCP-1 and that the MCP-1 production is inhibited by dexamethasone. We suggest that MCP-1 produced by GECs may play a role in the recruitment of monocytes/macrophages in glomerulonephritis and that the therapeutic effect glucocorticoid on the disease might include the inhibition of the production of MCP-1.
肾小球上皮细胞(GECs)已被证明是肾小球肾炎免疫性和非免疫性肾小球损伤中的一类靶细胞,其中一些病例伴有单核细胞/巨噬细胞浸润肾小球。在本研究中,我们检测了培养的GECs是否产生单核细胞趋化蛋白-1(MCP-1),这是一种在炎症中负责单核细胞募集的潜在分子,以及其产生是否受到糖皮质激素的抑制。GECs取自大鼠肾小球的生长物。分别通过Northern印迹分析和ELISA测定MCP-1 mRNA和蛋白的水平。Northern印迹分析显示细胞因子处理的GECs中MCP-1 mRNA的表达。地塞米松抑制MCP-1 mRNA的表达。ELISA定量分析证实了GECs产生MCP-1蛋白以及地塞米松的抑制作用。这些结果表明细胞因子处理的GECs产生并分泌MCP-1,且MCP-1的产生受到地塞米松的抑制。我们认为GECs产生的MCP-1可能在肾小球肾炎中单核细胞/巨噬细胞的募集中起作用,并且糖皮质激素对该疾病的治疗作用可能包括抑制MCP-1的产生。